Avalo Therapeutics, Inc.'s Net Worth
$24.2 Million
Who is Avalo Therapeutics, Inc.?
Avalo Therapeutics, Inc. has an estimated net worth of $24.2 Million. This is based on reported shares in AYTU BIOSCIENCE, INC.
SEC CIK
Avalo Therapeutics, Inc.'s CIK is 0001534120
Past Insider Trading and Trends
2020 was Avalo Therapeutics, Inc.'s most active year for acquiring shares with 1 total transactions. Avalo Therapeutics, Inc.'s most active month to acquire stocks was the month of March. 2020 was Avalo Therapeutics, Inc.'s most active year for disposing of shares, totalling 2 transactions. Avalo Therapeutics, Inc.'s most active month to dispose stocks was the month of March. 2020 saw Avalo Therapeutics, Inc. paying a total of $0.00 for 9,805,845 shares, this is the most they've acquired in one year. In 2020 Avalo Therapeutics, Inc. cashed out on 9,898,622 shares for a total of $144,091.96, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
AYTU BIOSCIENCE, INC (AYTU) Snapshot price: $2.48
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
∞
| 9.71M |
$1.55 | -$144,091.96 | 9.71M |
Apr 10 - Apr 15
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||